Have met this guy and have talked to scientists he worked with. It is actually a big positive that he is no longer involved with BIND and running R&D.
Just emerged from Forward Pharma. It will be a battle. Likely they cut a deal with Forward that gives Forward significant royalties on Tecfidera's $2.9B in sales, or they potentially lose IP protection on their blockbuster. Not good either way.